1 Recommendations

1 Recommendations

1.1 Current evidence on the safety and efficacy of the insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure is limited in both quality and quantity. Therefore this procedure should only be used with special arrangements for clinical governance, consent and audit or research.

1.2 Clinicians wishing to insert and use implantable pulmonary artery pressure monitors in chronic heart failure should take the following actions.

  • Inform the clinical governance leads in their Trusts.

  • Ensure that patients and their carers understand the uncertainty about the procedure's efficacy and safety and provide them with clear written information. In addition, the use of NICE's information for the public is recommended.

  • Audit and review clinical outcomes of all patients having pulmonary artery pressure monitors inserted (see section¬†7.1).

1.3 NICE encourages further research into the insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure, particularly studies that look at their long-term effects on hospital admissions and quality of life and that record adverse events.

  • National Institute for Health and Care Excellence (NICE)